Who
Michael Ryan Gorenstein
See remarks below
Company insider
Files Form 4 as: See remarks below, Cronos Group.
In numbers
- Trades disclosed
- 110
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $21.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Sep 2020
- Last trade
- 15 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —324,540 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $319K127,706 at $2.50 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —324,540 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —324,540 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —324,540 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $319K127,706 at $2.50 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —339,879 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $340K132,991 at $2.56 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —339,879 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —339,879 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —339,879 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $340K132,991 at $2.56 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —904,669 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —904,669 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —327,801 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $331K128,918 at $2.57 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —327,801 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —327,801 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —327,801 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $331K128,918 at $2.57 | filing |
News
Comparing Cronos Group (NASDAQ:CRON) and Eton Pharmaceuticals (NASDAQ:ETON)CRON · dailypolitical.com · 13 Oct 2026Reviewing Cronos Group (NASDAQ:CRON) and Urogen Pharma (NASDAQ:URGN)CRON · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Michael Ryan Gorenstein; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.